Study of the Week: Severe Atopic Dermatitis May Increase Non-Hodgkin Lymphoma Risk
source: pixabay.com

Study of the Week: Severe Atopic Dermatitis May Increase Non-Hodgkin Lymphoma Risk

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Severe Atopic Dermatitis May Increase Non-Hodgkin Lymphoma Risk
SHR0302 Helps Clear Severe AD, Study Says
https://unsplash.com/photos/tWTFjznQlBA

SHR0302 Helps Clear Severe AD, Study Says

According to MedPage Today, data from a preliminary study evaluating SHR0302, an investigational Janus kinase 1 (JAK1) inhibitor, showed promise for treating patients with moderate-to-severe atopic dermatitis (AD). Following treatment,…

Continue Reading SHR0302 Helps Clear Severe AD, Study Says
Patients to Be Recruited Into ASLAN004 Expansion Cohort for Atopic Dermatitis
Deedee86 / Pixabay

Patients to Be Recruited Into ASLAN004 Expansion Cohort for Atopic Dermatitis

  In a recent press release, biopharmaceutical company ASLAN Pharmaceuticals ("ASLAN") announced that it would begin recruiting patients for an expansion cohort of a clinical trial evaluating ASLAN004 for patients…

Continue Reading Patients to Be Recruited Into ASLAN004 Expansion Cohort for Atopic Dermatitis
The Drug Dupixent Shows Potential as an Eosinophilic Esophagitis Treatment
source: pixabay.com

The Drug Dupixent Shows Potential as an Eosinophilic Esophagitis Treatment

According to a story from GlobeNewswire, the medication dupilumab (marketed as Dupixent®) has demonstrated potential efficacy in a phase 3 clinical trial as a treatment for eosinophilic esophagitis, a rare…

Continue Reading The Drug Dupixent Shows Potential as an Eosinophilic Esophagitis Treatment
Potential Treatment for Lupus is Granted Fast Track Designation From the FDA
frolicsomepl / Pixabay

Potential Treatment for Lupus is Granted Fast Track Designation From the FDA

According to a story from BioSpace, Incyte Corporation and Eli Lilly and Company recently announced that the US Food and Drug Administration (FDA) has given the drug baricitinib Fast Track…

Continue Reading Potential Treatment for Lupus is Granted Fast Track Designation From the FDA
Throw Out the Bleach (Not the Baby) and Keep the Bath Water When Seeking Relief from Severe Atopic Dermatitis
StockSnap / Pixabay

Throw Out the Bleach (Not the Baby) and Keep the Bath Water When Seeking Relief from Severe Atopic Dermatitis

When you suffer with severe atopic dermatitis you can get pretty desperate to do anything to relieve the itch and other symptoms. So taking a bleach-bath is not out of…

Continue Reading Throw Out the Bleach (Not the Baby) and Keep the Bath Water When Seeking Relief from Severe Atopic Dermatitis
Severe Atopic Dermatitis May Be Less Rare Than We Realize
https://pixabay.com/en/globe-earth-world-globalization-895580/

Severe Atopic Dermatitis May Be Less Rare Than We Realize

Contagion Live (Infectious Diseases Today) recently discussed a journal article on the prevalence of atopic dermatitis. The simple summary? More research is needed to uncover just how common this condition is. BUT…

Continue Reading Severe Atopic Dermatitis May Be Less Rare Than We Realize